GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC10981 structure
    GC10981Disodium (R)-2-Hydroxyglutarate
    CAS: 103404-90-6
    Purity: >95.00%

    ثنائي الصوديوم (R) -2-Hydroxyglutarate (ثنائي الصوديوم (R) -2-هيدروكسيجلوتارات) هو المستقلب الرئيسي المتراكم في مرض الاستقلاب العصبي D-2-hydroxyglutaric aciduria.

  • GC11032 structure
    GC11032Cl-Amidine (trifluoroacetate salt)
    CAS: 1043444-18-3
    Purity: >97.00%

    مثبط نشاط الديمينيزيون لـ PAD4.

  • GC11034 structure
    GC11034TP-808
    CAS: 852821-06-8
    Purity: >98%

    intermediate for the synthesis of diverse tetracycline antibiotics

  • GC11163 structure
    GC11163L-NMMA (citrate)
    Purity: >98.00%

    relatively non-selective inhibitor of all NOS isoforms

  • GC11168 structure
    GC11168Motolimod (VTX-2337)
    CAS: 926927-61-9
    Purity: >98.00%

    Motolimod (VTX-2337) (VTX-2337 ؛ VTX-378) هو ناهض انتقائي لمستقبل 8 (TLR8) ، مع EC50 بحوالي 100 نانومتر.

  • GC11170 structure
    GC11170Choline Fenofibrate
    CAS: 856676-23-8
    Purity: >98.00%
  • GC11173 structure
    GC111731,3-PBIT (dihydrobromide)
    CAS: 200716-66-1
    Purity: >98%

    potent inhibitor of iNOS

  • GC11294 structure
    GC11294TAK-242 S enantiomer
    CAS: 243984-10-3
    Purity: >98.00%

    TLR 4 signaling inhibitor

  • GC11302 structure
    GC11302Hinokitiol
    CAS: 499-44-5
    Purity: >98.00%

    Hinokitiol هو أحد مكونات الزيوت الأساسية المعزولة من Chymacyparis obusa ، ويقلل من تعبير Nrf2 ، ويقلل DNMT1 و UHRF1 mRNA وتعبير البروتين ، مع أنشطة مضادة للعدوى ومضادة للأكسدة ومضادة للورم

  • GC11323 structure
    GC11323α-Guanidinoglutaric Acid
    CAS: 73477-53-9
    Purity: >98%

    linear mixed-type inhibitor of nNOS

  • GC11328 structure
    GC11328Cyclosporine
    CAS: 59865-13-3
    Purity: >99.50%

    عقار مثبط للمناعة

  • GC11443 structure
    GC11443Allylthiourea
    CAS: 109-57-9
    Purity: >98.00%

    الأليلثيوريا هو مثبط استقلابي انتقائي يمنع أكسدة الأمونيا

  • GC11461 structure
    GC11461CU CPT 4a
    CAS: 1279713-77-7
    Purity: >98.00%

    CU CPT 4a (TLR3-IN-1) هو مثبط إشارة TLR3 قوي وانتقائي للغاية. يقوم CU CPT 4a بقمع التعبير عن مسارات إشارات المصب بوساطة مجمع TLR3 / dsRNA ، بما في ذلك TNF-α و IL-1β.

  • GC11508 structure
    GC11508IKK-2 inhibitor VIII
    CAS: 406209-26-5
    Purity: >99.50%
  • GC11513 structure
    GC11513Zofenopril calcium
    CAS: 81938-43-4
    Purity: >99.50%

    Zofenopril Calcium (SQ26991) هو أحد مضادات الأكسدة التي تعمل كمثبط للإنزيم المحول للأنجيوتنسين

  • GC11609 structure
    GC11609Nω-Propyl-L-arginine hydrochloride
    CAS: 137361-05-8
    Purity: >98%

    neuronal nitric oxide synthase (nNOS) inhibitor

  • GC11660 structure
    GC11660Nitisinone
    CAS: 104206-65-7
    Purity: >99.50%

    Nitisinone هو مثبط 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) نشط عن طريق الفم وتنافسي وقابل للانعكاس مع IC50 من 173 نانومتر

  • GC11664 structure
    GC11664YM 90709
    CAS: 163769-88-8
    Purity: >99.50%

    YM 90709 هو مثبط جديد لـ IL-5 والذي يمنع بشكل انتقائي ارتباط IL-5 بمستقبل IL-5 (IL-5R).

  • GC11670 structure
    GC11670Pranoprofen
    CAS: 52549-17-4
    Purity: >98.00%

    Pranoprofen هو عامل مضاد للالتهابات غير ستيرويدي (NSAID) لأبحاث التهاب القرنية أو أمراض العيون الأخرى

  • GC11698 structure
    GC11698Valaciclovir HCl
    CAS: 124832-27-5
    Purity: >98%

    Valaciclovir HCl (فالاسيكلوفير هيدروكلوريد) هو دواء مضاد للفيروسات فعال عن طريق الفم لعلاج الهربس البسيط والهربس النطاقي والهربس ب.

  • GC11702 structure
    GC11702DL-Carnitine HCl
    CAS: 461-05-2
    Purity: >98.00%

    يوجد DL-Carnitine HCl في اثنين من أيزومرين ، يُعرفان باسم D و L.

  • GC11707 structure
    GC11707L-Ascorbyl 6-palmitate
    CAS: 137-66-6
    Purity: >99.00%

    يتكون ل-أسكوربيل 6-بالميتات من حمض الأسكوربيك وحمض البالميتيك، مما يخلق فيتامين سي، كما يستخدم أيضًا كإضافة غذائية مضادة للأكسدة.

  • GC11736 structure
    GC11736NF-κB Activation Inhibitor III
    CAS: 380623-76-7
    Purity: >98%

    NF-κ ؛ B Activation Inhibitor III هو مثبط قوي لـ NF-kB يستهدف تنشيط MAPK p38 المصب. NF-κ ؛ B Activation Inhibitor III يثبط TNF-α ؛ تنظيم MMP-9 الناجم. NF-κ ؛ B Activation Inhibitor III يمكن استخدامه للبحث في العلاجات الكيميائية التي تستهدف TNF-α ؛ غزو الورم ورم خبيث بوساطة.

  • GC11743 structure
    GC11743MF63
    CAS: 892549-43-8
    Purity: >99.00%

    A potent, selective, and orally active mPGES-1 inhibitor